Tonix pharmaceuticals holding corp

Major-Pharmaceuticals

TNXP


509 Madison Avenue
New York , NY 10022

Executive/
Director

Price

  • Last Close
  • $ 0.35
    $ -0.16 -30.84 %
    May 9, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 6,920,385
  • Market Cap Full
  • $ 8.3M
  • Shares Outstanding
  • 23.8M
    Nov 9, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -68.6% -0.7% -13% 9.6% -5% 88.2% -36.1% 51.5% - -
Q2 -17.4% -7.3% 54% -44.7% 4% -13.3% 587% -40.4% - -
Q3 -65% 5.3% -85.8% -69.5% 8% -46% -66.5% - - -
Q4 -32.6% -20% -63.3% 177% -19.1% -40% -26.4% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    31%-94%-27%-94%-46%-43%-47%8%-10%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.74 1.27 -8.8 -1.29 -0.37 -0.07 -1.6 -3.25
Q2 0.50 0.65 -7.3 -0.95 -0.23 -0.07 -1.22 -2.68
Q3 0.26 0.70 -5.7 -5.69 -0.09 -0.05 -0.69 -1.83
Q4 1.77 0.67 -5.01 8.54 0.14 -2.01 1.48 -
A 3.3 3.3 -26.8 0.6 -0.55 -8.1 -3.3 -7.76

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 6.1 49.4 323.9 533.9 62.5
Jun 8.5 6.1 52.3 326.5 599.7 64.6
Sep 9.5 15.4 130.3 357.5 43.1 17.8
Dec 14.2 1.6 156.6 439.6 57.5 23.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 56 - 51 - -8.7
Equity multiplier 0.5 0.2 0.1 - -